|
US4250262A
(en)
*
|
1979-12-14 |
1981-02-10 |
Forsyth Dental Infirmary For Children |
Method of preparing a purified glucosyltransferase
|
|
US5139933A
(en)
*
|
1989-09-26 |
1992-08-18 |
Vicam, L.P. |
Assay method for detecting listeria
|
|
US5571511A
(en)
*
|
1990-10-22 |
1996-11-05 |
The U.S. Government |
Broadly reactive opsonic antibodies that react with common staphylococcal antigens
|
|
US5290707A
(en)
*
|
1991-11-25 |
1994-03-01 |
The United States Of America As Represented By The Secretary Of The Army |
Method for detection of microorganisms
|
|
US5367058A
(en)
*
|
1993-08-25 |
1994-11-22 |
Becton, Dickinson And Company |
Modified antibodies with increased affinity
|
|
JP3814290B2
(ja)
*
|
1993-12-09 |
2006-08-23 |
エスクナー，ハインリッヒ |
抗原用のアジュバントおよびその製法ならびに用途
|
|
US6350597B1
(en)
*
|
1994-01-13 |
2002-02-26 |
E. I. Du Pont De Nemours & Company |
Riboflavin synthase genes and enzymes and methods of use
|
|
US6203997B1
(en)
*
|
1994-06-08 |
2001-03-20 |
Sepsis, Inc. |
Quantitation of analytes in whole blood
|
|
CA2208780C
(en)
*
|
1995-01-30 |
2010-03-30 |
Peter Truog |
Antitumor and anticholesterol preparations comprising lipoteichoic acid lta-t of streptococcus sp dsm 8747
|
|
CA2232230C
(en)
*
|
1995-10-13 |
2005-06-28 |
Ralph H. Lambalot |
Phosphopantetheinyl transferases and uses thereof
|
|
US5770208A
(en)
*
|
1996-09-11 |
1998-06-23 |
Nabi |
Staphylococcus aureus B-linked hexosamine antigen
|
|
US6610293B1
(en)
*
|
1997-06-16 |
2003-08-26 |
The Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
|
|
US5889171A
(en)
*
|
1997-07-18 |
1999-03-30 |
Smithkline Beecham Corporation |
TarF
|
|
HUP0002662A3
(en)
*
|
1997-07-23 |
2003-08-28 |
Ambi Inc |
Pharmaceutical compositions containing lysostaphin alone or in combination with an antibiotic for the treatment of staphylococcal infections
|
|
US7250494B2
(en)
*
|
1998-06-15 |
2007-07-31 |
Biosynexus Incorporated |
Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria
|
|
US7252828B2
(en)
*
|
1998-07-15 |
2007-08-07 |
The Brigham And Women's Hospital, Inc. |
Polysaccharide vaccine for staphylococcal infections
|
|
US6703025B1
(en)
*
|
1998-08-31 |
2004-03-09 |
Inhibitex, Inc. |
Multicomponent vaccines
|
|
US6585973B1
(en)
*
|
1998-10-29 |
2003-07-01 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Method for preparing solid phase conjugated vaccine
|
|
CN101066447A
(zh)
*
|
1998-12-22 |
2007-11-07 |
微科学有限公司 |
基因和蛋白质,及它们的用途
|
|
US6569830B1
(en)
*
|
1999-03-05 |
2003-05-27 |
Ambi, Inc. |
Compositions and methods for treatment of staphylococcal infection while suppressing formation of antibiotic-resistant strains
|
|
CN1355690A
(zh)
*
|
1999-04-16 |
2002-06-26 |
奥赛尔股份有限公司 |
一种延长可溶性病毒特异性配体在粘膜上半寿期的方法
|
|
US6974700B2
(en)
*
|
1999-06-14 |
2005-12-13 |
Martin Levine |
Kit for use in predicting refractory periodontal disease
|
|
WO2002045742A2
(en)
*
|
2000-09-12 |
2002-06-13 |
U.S. Army Medical Research And Materiel Command |
Lipoteichoic acid immunogenic compositions and methods of making and using thereof
|
|
GB0107661D0
(en)
*
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Staphylococcus aureus
|
|
US20030113350A1
(en)
*
|
2001-09-19 |
2003-06-19 |
Fattom Ali I. |
Glycoconjugate vaccines for use in immune-compromised populations
|
|
US6720160B2
(en)
*
|
2001-10-11 |
2004-04-13 |
Helica Biosystems, Inc. |
Method for simultaneous detection of multiple microbial antigens in biological specimens from mastitic animals
|
|
US7169903B2
(en)
*
|
2001-12-21 |
2007-01-30 |
Biosynexus Incorporated |
Multifunctional monoclonal antibodies directed to peptidoglycan of gram-positive bacteria
|
|
WO2003066649A1
(en)
*
|
2002-02-04 |
2003-08-14 |
Biomira Inc. |
Immunostimulatory, covalently lipidated oligonucleotides
|
|
FR2842210B1
(fr)
*
|
2002-07-09 |
2012-12-14 |
Mutabilis |
Determinants de pathogenicite utilisables comme cibles pour l'elaboration de moyens de prevention et de controle d'infections bacteriennes et/ou de la dissemination systemique
|
|
US20040109853A1
(en)
*
|
2002-09-09 |
2004-06-10 |
Reactive Surfaces, Ltd. |
Biological active coating components, coatings, and coated surfaces
|
|
US7348420B2
(en)
*
|
2003-04-25 |
2008-03-25 |
North Carolina State University |
Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore
|
|
US7422755B2
(en)
*
|
2004-01-15 |
2008-09-09 |
The United States Of America As Represented By The Department Of Health And Human Services |
Antimultiorganism glycoconjugate vaccine
|
|
KR100596443B1
(ko)
*
|
2004-04-27 |
2006-07-05 |
주식회사 하이닉스반도체 |
다수 뱅크 구조 디램을 위한 리프레시 제어회로 및 그 방법
|
|
US20060134141A1
(en)
*
|
2004-12-14 |
2006-06-22 |
Nabi Biopharmaceuticals |
Glycoconjugate vaccines containing peptidoglycan
|
|
US20060228368A1
(en)
*
|
2005-04-07 |
2006-10-12 |
Nabi Biopharmaceuticals |
Method of protecting against staphylococcal infection
|
|
EP1871868A2
(en)
*
|
2005-04-15 |
2008-01-02 |
North Carolina State University |
Methods and compositions to modulate adhesion and stress tolerance in bacteria
|
|
US7521535B2
(en)
*
|
2006-09-20 |
2009-04-21 |
The Board Of Regents For Oklahoma State University |
Anti-microbial defensin-related peptides and methods of use
|